Cytarabine 71288-0108
Product NDC
71288-0108- Manufacturer
- Meitheal Pharmaceuticals Inc.
- Dosage Form
- Injection, Solution
- Route
- Intrathecal, Intravenous, And Subcutaneous
- Product Type
- Human Prescription Drug
- Marketing Start
- June 26, 2020
- Listing Expires
- December 31, 2026
- Application
- ANDA206189
Need to source Cytarabine? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Cytarabine | 20 mg/mL |
Drug Class
Nucleoside Metabolic Inhibitor [EPC]Nucleic Acid Synthesis Inhibitors [MoA]Nucleoside Metabolic Inhibitor [EPC]
Packaging Options(1)
5 VIAL, SINGLE-DOSE in 1 CARTON (71288-108-06) / 5 mL in 1 VIAL, SINGLE-DOSE (71288-108-05)